Arete Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,117
| Closed | -$1.6M | – | 818 |
|
|
2025
Q1 | $1.6M | Sell |
12,117
-12,100
| -50% | -$1.6M | 0.12% | 171 |
|
|
2024
Q4 | $2.02M | Sell |
24,217
-850
| -3% | -$71K | 0.15% | 139 |
|
|
2024
Q3 | $1.83M | Buy |
25,067
+4,517
| +22% | +$330K | 0.16% | 134 |
|
|
2024
Q2 | $1.41M | Sell |
20,550
-5,065
| -20% | -$347K | 0.12% | 176 |
|
|
2024
Q1 | $1.77M | Sell |
25,615
-43
| -0.2% | -$2.98K | 0.16% | 144 |
|
|
2023
Q4 | $1.84M | Buy |
25,658
+81
| +0.3% | +$5.8K | 0.14% | 153 |
|
|
2023
Q3 | $1.33M | Buy |
+25,577
| New | +$1.33M | 0.23% | 97 |
|